GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Ending Cash Position

Diasorin SpA (LTS:0GZX) Ending Cash Position : €308 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Ending Cash Position?

Diasorin SpA's Ending Cash Position for the quarter that ended in Mar. 2024 was €308 Mil.

Diasorin SpA's quarterly Ending Cash Position increased from Sep. 2023 (€243 Mil) to Dec. 2023 (€280 Mil) and increased from Dec. 2023 (€280 Mil) to Mar. 2024 (€308 Mil).

Diasorin SpA's annual Ending Cash Position declined from Dec. 2021 (€403 Mil) to Dec. 2022 (€242 Mil) but then increased from Dec. 2022 (€242 Mil) to Dec. 2023 (€280 Mil).

Diasorin SpA Ending Cash Position Historical Data

The historical data trend for Diasorin SpA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Ending Cash Position Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157.55 339.88 403.02 241.78 280.31

Diasorin SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 373.00 256.30 243.00 280.31 308.00

Diasorin SpA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Diasorin SpA's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=241.775+38.539
=280

Diasorin SpA's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=281+27
=308

Diasorin SpA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA (LTS:0GZX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Ending Cash Position
Comparable Companies
HKSE:00712 HKSE:08609 HKSE:08070 HKSE:01527 HKSE:01933 HKSE:08160 HKSE:00380 HKSE:01749 HKSE:01273 HKSE:00483 TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN
Traded in Other Exchanges
DSRLF:USA DIA:Italy 34D:Germany
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.

Diasorin SpA (LTS:0GZX) Headlines

No Headlines